实用医学杂志 ›› 2026, Vol. 42 ›› Issue (4): 551-558.doi: 10.3969/j.issn.1006-5725.2026.04.002

• 慢性病防治专栏 • 上一篇    下一篇

星状神经节阻滞治疗失眠的临床研究进展

刘淑桢1,2,王朝丽1,2,何美姮1,2,赵岚1,2()   

  1. 1.天津中医药大学第一附属医院 (天津 300381 )
    2.中医国家临床医学研究中心 (天津 300381 )
  • 收稿日期:2025-10-15 出版日期:2026-02-25 发布日期:2026-02-25
  • 通讯作者: 赵岚 E-mail:lanzhao69@163.com
  • 基金资助:
    国家中医针灸临床医学研究中心开放课题项目(NCRCOP2023007)

Clinical research progress in stellate ganglion block for insomnia treatment

Shuzhen LIU1,2,Chaoli WANG1,2,Meiheng HE1,2,Lan ZHAO1,2()   

  1. 1.First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,Tianjin,China
    2.National Clinical Research Center for Chinese Medicine,Tianjin 300381,Tianjin,China
  • Received:2025-10-15 Online:2026-02-25 Published:2026-02-25
  • Contact: Lan ZHAO E-mail:lanzhao69@163.com

摘要:

星状神经节阻滞(stellate ganglion block, SGB)是一种通过局部麻醉药物暂时阻断颈胸段交感神经传导的神经调节技术。近年来,该技术在失眠治疗领域受到广泛关注,并展现出显著的临床疗效。失眠作为一种常见的睡眠障碍,其发生与交感神经系统过度活跃密切相关,常表现为入睡困难、睡眠维持障碍、早醒及醒后疲劳等核心症状。SGB能够精准抑制异常增高的交感神经兴奋性,并通过调节神经递质平衡、抑制炎症反应及调控神经内分泌等多途径发挥协同作用,从而恢复正常的睡眠结构、全面提升睡眠质量。此外,该疗法还有助于患者逐渐减少对苯二氮?类等镇静药物的依赖,降低因长期服药导致的耐受和不良反应风险。该综述系统梳理SGB在原发性与继发性失眠中的临床应用现状,深入分析其作用机制并评估安全性,为进一步完善个体化治疗方案、探索机制靶点及推进临床规范应用提供参考。

关键词: 星状神经节阻滞, 原发性失眠, 继发性失眠, 临床疗效

Abstract:

Stellate ganglion block (SGB) is a neuromodulation technique that temporarily blocks sympathetic nerve conduction in the cervical-thoracic region using local anesthetic drugs. In recent years, this technique has garnered significant attention in the field of insomnia treatment and has demonstrated notable clinical efficacy. Insomnia is a common sleep disorder closely related to overactivity of the sympathetic nervous system, often manifested by core symptoms such as difficulty falling asleep, sleep maintenance disorders, early awakening, and fatigue after awakening. SGB precisely suppresses abnormally heightened sympathetic nervous system excitability, exerting synergistic effects through multiple pathways including regulating neurotransmitter balance, inhibiting inflammatory responses, and modulating neuroendocrine functions. This restores normal sleep architecture and comprehensively enhances sleep quality. Additionally, this therapy helps patients gradually reduce their dependence on sedative medications such as benzodiazepines, thereby lowering the risks of tolerance and adverse reactions associated with long-term medication use. This review systematically summarizes the current clinical application of SGB in primary and secondary insomnia, deeply analyzes its mechanisms of action, and evaluates its safety, providing references for further refining individualized treatment plans, exploring mechanism targets, and promoting standardized clinical application.

Key words: stellate ganglion block, primary insomnia, secondary insomnia, clinical efficacy

中图分类号: